Treatment-Resistant HIV May Have Met Its Match
A new study shows hope for the 10 percent of HIV-positive patients who cannot rely on initial treatment meds.
February 23 2023 4:12 PM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A new study shows hope for the 10 percent of HIV-positive patients who cannot rely on initial treatment meds.
The first Phase 3 trial for a potential HIV vaccine has ended in disappointment.
The vaccine uses an engineered protein from within the virus.
Gilead Sciences has backed George Washington University for the 18-month initiative.
Canadian researchers look at how non-neutralizing antibodies affect the virus.
Recent research shows the popular HIV treatment drug is a safe and highly effective treatment option for those also living with hepatitis B.
The drug company revealed promising long-term data at the 2022 Glasgow HIV conference, including news on cure development.
A government grant will fund an HIV-focused biomedical research space at Whitman-Walker Health.
Here’s the latest on a genetic editing technique with the potential to permanently eliminate HIV from the body.
A woman is in HIV “remission” due to a rare and risky procedure but the White House's Dr. Anthony Fauci warns this method can't be “applied to the 36 million who are living with HIV.”
Though the “highly virulent” strain was just identified, it’s actually been around since the ’90s and is easily controlled by HIV treatment.
Longtime survivor Marc Wagner has dedicated his life to aiding the HIV research community.
A new “block and lock” curative approach could solve the problem of viral reservoirs and permanently silence HIV.
Heart disease risk factors such as smoking or having high blood pressure increased the risk even further in those with HIV.
The study came from a clinic based in the heart of London's gay scene.
Johnson & Johnson's attempted vaccine didn't have the efficacy necessary for the study to continue.
The Martin Delaney Collaboratory of AIDS Researchers for Eradication is just one institution that will receive part of $265 million to end HIV.
The American Cancer Society estimates there will be almost 250,000 new cases of prostate cancer this year and about 34,000 men will die from the disease.
A new study explores how HIV reduces white matter, which is known to affect motor and cognitive skills.
An experimental HIV vaccine that led to increased risk of contracting the virus had similarities to some of the COVID-19 vaccines in development.